← FDA DRUG APPROVALS

FDA ANDA · ANDA074947

CLOMIPRAMINE HYDROCHLORIDE

Sponsor: PHARMOBEDIENT

APPLICATION
ANDA074947
TYPE
ANDA
ORIGINAL APPROVAL
1998-04-30
LATEST ACTION
2016-12-29
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Discontinued

Products

CLOMIPRAMINE HYDROCHLORIDEDiscontinued
CLOMIPRAMINE HYDROCHLORIDE 75MG · CAPSULE · ORAL
CLOMIPRAMINE HYDROCHLORIDEDiscontinued
CLOMIPRAMINE HYDROCHLORIDE 25MG · CAPSULE · ORAL
CLOMIPRAMINE HYDROCHLORIDEDiscontinued
CLOMIPRAMINE HYDROCHLORIDE 50MG · CAPSULE · ORAL

Approval history

2016-12-29Labeling · Supplement 16 · standardAP
2013-03-18Labeling · Supplement 15 · standardAP
2007-10-16Labeling · Supplement 10AP
2007-07-09Labeling · Supplement 8AP
2005-05-03Labeling · Supplement 4AP
2003-10-31Labeling · Supplement 3AP
2001-12-11Labeling · Supplement 2AP
2001-08-03Labeling · Supplement 1AP
1998-04-30OriginalLetterAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →